_PRIVATE_LIMITED.webp)
Pharmax India Profile
Key Indicators
- Authorised Capital ₹ 3.60 Cr
as on 03-06-2024
- Paid Up Capital ₹ 1.26 Cr
as on 03-06-2024
- Company Age 65 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 14.60 Cr
as on 03-06-2024
- Satisfied Charges ₹ 5.03 Cr
as on 03-06-2024
- Revenue 8.20%
(FY 2022)
- Profit 24.78%
(FY 2022)
- Ebitda 27.12%
(FY 2022)
- Net Worth 72.74%
(FY 2022)
- Total Assets 18.04%
(FY 2022)
About Pharmax India
The Corporate was formerly known as Pharmax Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.60 Cr and a paid-up capital of Rs 1.26 Cr.
The company currently has active open charges totaling ₹14.60 Cr. The company has closed loans amounting to ₹5.03 Cr, as per Ministry of Corporate Affairs (MCA) records.
Bimlesh Bansal, Suyash Bansal, and Sarvesh Bansal serve as directors at the Company.
- CIN/LLPIN
U24100MH1959PTC011403
- Company No.
011403
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jul 1959
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Pharmax India Private Limited offer?
Pharmax India Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Anti Infective Agent, Antibacterial Drugs, Animal Medicines & Health Care, Veterinary Medicines, Anticoagulant and Antiplatelet Drugs, Heparin Injection, Anthelmintics, Malaria Medicine, Common Disease Medicines.
Who are the key members and board of directors at Pharmax India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sarvesh Bansal  | Managing Director | 31-Aug-1994 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bimlesh Bansal | Director | 14-Mar-1994 | Current |
| Suyash Bansal | Director | 28-Sep-2017 | Current |
Financial Performance and Corporate Structure Insights of Pharmax India.
Pharmax(India) Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 8.2% increase. The company also saw a substantial improvement in profitability, with a 24.78% increase in profit. The company's net worth Soared by an impressive increase of 72.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmax India?
In 2022, Pharmax India had a promoter holding of 97.20% and a public holding of 2.79%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pharmax Renewable Private Limited
Active 2 months 17 daysBimlesh Bansal and Sarvesh Bansal are mutual person
Kiran Wire Products Private Limited
Active 44 years 3 monthsSuyash Bansal and Sarvesh Bansal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 20 May 2022 | ₹1.30 Cr | Open |
Others Creation Date: 27 Mar 2021 | ₹13.00 Cr | Open |
State Bank Of India Creation Date: 10 Jun 1994 | ₹3.00 M | Open |
How Many Employees Work at Pharmax India?
Pharmax India has a workforce of 54 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmax India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmax India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
